Use access key #2 to skip to page content.
$21.52 -0.61 (-2.76%)
7/18/2008 1:46 PM

Schering-Plough Corp (SGP)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating SGP

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

1002 Outperforms
51 Underperforms
 

All-Stars

330 Outperforms
11 Underperforms
 

Wall Street

16 Outperforms
0 Underperforms
 

Players bullish on SGP are also bullish on:

Players bearish on SGP are also bearish on:

Ticker Tags

Big Pharma (12), Six Sigma® (37), S&P 500 (481), Drug Manufacturers - Major (27), Pharmaceutical (30), Dividend (202), New Jersey (8), Large Cap (467)
Suggest a tag

Schering-Plough Corp At A Glance

Current Price: $21.52
Last Trade Time: 7/18/2008 1:46 PM
Open: $21.91
Previous Close: $22.13
Daily Range: $21.49 - $22.50
52-Week Range: $13.83 - $33.40
Volume: 12,575,357
Market Cap: $35.88B
P/E Ratio: 16.04
Compare Our Special Broker Offers!

Stock Trends

SGP VS S&P 500 (SPY)

SGP 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for SGP

More Headlines...

Top Bull Pitch

Recs

13

Schering-Plough Corp (SGP)

Avatar KamranatUCLA (78.35) Submitted: 3/28/08 12:40 AM

This is my story and why i picked this stock.
Once upon a time there was a young Iranian boy who moved to Germany at the age of 15 in hopes of better life and in order to escape the horrible war, and because all his friends went either to war or to other countries.
This young man had a lot of proble...More

Replies: 3 | Reply | Permalink

Top Bear Pitch

Recs

2

Schering-Plough Corp (SGP)

Avatar spiderone27 (97.92) Submitted: 6/08/07 4:18 PM

This stock has some trouble ahead in the future, I don't see it climbing much much higher before it takes a fall.

Replies: 1 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 157 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (SGP)

Avatar diverjdp (< 20) Submitted: 7/16/08 10:56 AM : Outperform Start Price: $22.54 SGP Score: -6.27

Love the drug stocks in this environment.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SGP)

Avatar eleev (46.68) Submitted: 7/15/08 12:23 AM : Outperform Start Price: $21.80 SGP Score: -3.58

has been hit, but has good products.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SGP)

Avatar caseykimma (90.68) Submitted: 7/10/08 11:17 PM : Outperform Start Price: $21.59 SGP Score: -1.19

big pharma seems to be making a move up, at least for the short term...try to capture a few points here, if not a few more

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SGP)

Avatar iStockInvestor (< 20) Submitted: 7/10/08 9:39 AM : Outperform Start Price: $21.93 SGP Score: -1.53

Pharmaceuticals are recovering from lows despite an overall decline in the markets.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SGP)

Avatar nikkobear (< 20) Submitted: 7/09/08 5:11 PM : Outperform Start Price: $21.72 SGP Score: -1.04

people will always need meds to cure them

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 157 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 16 of 16  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLehmanBros 87.62 07/15/08 Outperform NS $21.80-0.69%+2.89%-3.58
TrackAmTech 76.18 06/27/08 Outperform NS $19.07+13.53%-2.23%+15.76
TrackJPMorgan 93.66 06/25/08 Outperform NS $19.43+11.43%-4.86%+16.29
TrackRichPzena < 20 06/17/08 Outperform 1Y $19.26+12.41%-8.47%+20.88 Toggle the visibility of 60-Second Pitch and replies
TrackHAndW < 20 06/16/08 Outperform 1Y $19.09+13.41%-8.05%+21.46 Toggle the visibility of 60-Second Pitch and replies
TrackCarisandCo 78.93 04/21/08 Outperform NS $16.76+29.16%-9.50%+38.66
TrackBofASec 96.82 02/13/08 Outperform NS $22.34-3.10%-7.86%+4.76
TrackBernstein 77.21 10/24/07 Outperform NS $29.14-25.70%-17.12%-8.58
TrackHSBC 94.57 10/23/07 Outperform NS $28.48-23.99%-17.26%-6.73
TrackEveillard 89.79 09/30/07 Outperform NS $31.35-30.94%-17.86%-13.07 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 98.53 09/30/07 Outperform NS $31.35-30.94%-17.86%-13.07 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.94 09/30/07 Outperform NS $31.35-30.94%-17.86%-13.07 Toggle the visibility of 60-Second Pitch and replies
TrackBillNygren 76.67 09/30/07 Outperform NS $31.35-30.94%-17.86%-13.07 Toggle the visibility of 60-Second Pitch and replies
TrackUBS 96.80 08/13/07 Outperform NS $27.35-20.85%-14.46%-6.39
TrackBMOCapital 95.92 04/13/07 Outperform NS $27.18-20.33%-13.29%-7.04
TrackJimCramer 82.43 03/16/07 Outperform 3W $22.77-4.94%-9.53%+4.60

Results 1 - 16 of 16  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners